nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute lymphoblastic leukemia (ALL)
|
Advani, Anjali |
|
2017 |
30 |
3 |
p. 173-174 2 p. |
artikel |
2 |
Editorial Board / Aims & Scope
|
|
|
2017 |
30 |
3 |
p. iii- 1 p. |
artikel |
3 |
How do we measure MRD in ALL and how should measurements affect decisions. Re: Treatment and prognosis?
|
Chen, Xueyan |
|
2017 |
30 |
3 |
p. 237-248 12 p. |
artikel |
4 |
How is the Ph-like signature being incorporated into ALL therapy?
|
Maese, Luke |
|
2017 |
30 |
3 |
p. 222-228 7 p. |
artikel |
5 |
How should we treat a patient with relapsed Ph-negative B-ALL and what novel approaches are being investigated?
|
Gökbuget, Nicola |
|
2017 |
30 |
3 |
p. 261-274 14 p. |
artikel |
6 |
How should we treat older adults with Ph+ adult ALL and what novel approaches are being investigated?
|
Wieduwilt, Matthew J. |
|
2017 |
30 |
3 |
p. 201-211 11 p. |
artikel |
7 |
How should we treat the AYA patient with newly diagnosed ALL?
|
Boissel, Nicolas |
|
2017 |
30 |
3 |
p. 175-183 9 p. |
artikel |
8 |
Index
|
|
|
2017 |
30 |
3 |
p. I- 1 p. |
artikel |
9 |
Pharmacogenomics in acute lymphoblastic leukemia
|
Lee, Shawn H.R. |
|
2017 |
30 |
3 |
p. 229-236 8 p. |
artikel |
10 |
Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in older adults: Current treatment and novel therapies
|
O'Dwyer, Kristen M. |
|
2017 |
30 |
3 |
p. 184-192 9 p. |
artikel |
11 |
The biology of Philadelphia chromosome-like ALL
|
Roberts, Kathryn G. |
|
2017 |
30 |
3 |
p. 212-221 10 p. |
artikel |
12 |
The what, when and how of CAR T cell therapy for ALL
|
Frey, Noelle |
|
2017 |
30 |
3 |
p. 275-281 7 p. |
artikel |
13 |
Which patients should I transplant with acute lymphoblastic leukemia?
|
Inbar, Tsofia |
|
2017 |
30 |
3 |
p. 249-260 12 p. |
artikel |
14 |
Which tyrosine kinase inhibitor should we use to treat Philadelphia chromosome-positive acute lymphoblastic leukemia?
|
Short, Nicholas J. |
|
2017 |
30 |
3 |
p. 193-200 8 p. |
artikel |